Matrix metalloproteinases, IL-6, and nitric oxide in rat antigen- induced arthritis

Clinical and Experimental Rheumatology

Volumn 16, Issue 3, 1998, Pages 269-276

  Mentzel, K ^a   Brauer R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Antigen induced arthritis; Interleukin 6; Matrix metalloproteinases; Nitric oxide; Synovial fluid; Synoviocytes

Indexed keywords

GELATINASE B; INTERLEUKIN 1BETA; INTERLEUKIN 6; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; DEGRADATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOPATHOGENESIS; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, REACTIVE; CELLS, CULTURED; ENZYME ACTIVATION; FEMALE; GELATIN; INTERLEUKIN-1; INTERLEUKIN-6; MALE; METALLOENDOPEPTIDASES; NITRIC OXIDE; RATS; RATS, WISTAR; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031972206     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. HARRIS ED: Rheumatoid arthritis. N Engl J Med 1990; 322: 1277-89.
2. SCOTT DL, WILLOUGHBY DA, BLAKE DR: Molecular insights into rheumatoid arthritis. Molec Aspects Med 1991; 12: 341-94.
3. BOND JS, BEYNON RJ: Mammalian metalloendopeptidases. Int J Biochem 1985; 17: 565-74.
4. BIRKEDAL-HANSEN H, MOORE WGI, BODDEN MK et al.: Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 1993; 4: 197-250.
5. CORCORAN ML, HEWITT RE, KLEINER DE: MMP-2: Expression, activation and inhibition. Enzyme Protein 1996; 49: 7-19.
6. WOESSNER JF JR: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991; 5: 2145-54.
7. MURPHY G, MCGUIRE MB, RUSSELL RGG, REYNOLDS JJ: Characterization of collagenase, other metallo-proteinases and an inhibitor (TIMP) produced by human synovium and cartilage in culture. Clin Sci 1981; 61: 711-16.
8. TETLOW LC, LEES M, WOOLLEY DE: Comparative studies of collagenase and stromelysin-1 expression by rheumatoid synoviocytes in vitro. Virchows Archiv 1995; 425: 569-76.
9. HEMBRY RM, BAGGA MR, REYNOLDS JJ, HAMBLEN DI: Immunolocalization studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo-and rheumatoid arthritis. Ann Rheum Dis 1995; 54: 25-32.
10. DiBATTISTA JA, PELLETIER JP, ZAFARULLAH M et al.: Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J Rheumatol 1995; 22 (Suppl.43): 123-8.
11. CUNNANE G, SUMMERS C, TAYLOR D, CAWSTON T, BRESNIHAN B, FITZGERALD O: Elevated serum and synovial fluid levels of collagenase, stromelysin and tissue inhibitor of metalloproteinases (TIMP-1) in early inflammatory arthritis. Arthritis Rheum 1996; 39 (Suppl.): S132.
12. DURIE FH, FAVA RA, NOELLE RJ: Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 1994; 73: 11-18.
13. ZHANG J, WEICHMAN BM, LEWIS AJ: Role of animal models in the study of rheumatoid arthritis: An overview. In HENDERSON B, EDWARDS JCW, and PETTIPHER ER (Eds.): Mechanisms and Models in Rheumatoid Arthritis London, Academic Press 1995; 363-72.
14. BILLINGHAM MEJ: Adjuvant arthritis: the first model. In HENDERSON B, EDWARDS JCW, and PETTIPHER ER (Eds.): Mechanisms and Models in Rheumatoid Arthritis London, Academic Press 1995; 389-409.
15. HUTCHINSON NI, LARK MW, MACNAUL KL et al.: In vivo expression of stromelysin in synovium and cartilage of rabbits injected intra-articularly with interleukin-1β. Arthritis Rheum 1992; 35: 1227-33.
16. CASE JP, SANO H, LAFYATIS R, REMMERS EF, KUMKUMIAN GK, WILDER RL: Transin/ stromelysin expression in the synovium of rats with experimental erosive arthritis. J Clin Invest 1989; 84: 1731-40.
17. HASTY KA, REIFE RA, KANG AH, STUART JM: The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990; 33: 388-97.
18. HEMBRY RM, BAGGA MR, MURPHY G, REYNOLDS JJ: Rabbit models of arthritis: Immunolocalization of matrix metalloproteinases and tissue inhibitor of metalloproteinase in synovium and cartilage. Am J Pathol 1993; 143: 628-42.
19. DUMONDE DC, GLYNN LE: The production of arthritis in rabbits by an immunological reaction to fibrin. Br J Exp Pathol 1962; 43: 373-83.
20. HUNNEYBALLIM, CROSSLEY MJ, SPOWAGE M: Pharmacological studies of antigen-induced arthritis in BALB/C mice. II. The effects of second-line antirheumatic drugs and cytotoxic agents on the histopathological changes. Agents Actions 1986; 18: 394-400.
21. GEILER T, KRIEGSMANN J, KEYSZER GM, GAY RE, GAY S: A new model for rheumatoid arthritis generated by engraftment of rheumatoid synoviual tissue and normal human cartilage into seid mice. Arthritis Rheum 1994; 37: 1664-71.
22. MÜLLER-LADNER U, KRIEGSMANN J, FRANKLIN BN et al.: Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996; 149: 1607-15.
23. FEIST W, ULMER AJ, WANG MH et al.: Modulation of lipopolysaccharide-induced production of tumor necrosis factor, interleukin 1, and interleukin 6 by synthetic precursor Ia of lipid A. FEMS Microbiol Immunol 1992; 89: 73-90.
24. BRÄUER R, KETTE H, HENZGEN S, THOSS K: Influence of cyclosporin A on cytokine levels in synovial fluid and serum of rats with antigen-induced arthritis. Agents Actions 1994; 41: 96-8.
25. HOUSSIAU FA, DEVOGELAER JP, VAN DAMME J, DEDEUXCHAISNES CN, VAN SICK J: Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides. Arthritis Rheum 1988; 31: 784-8.
26. SENTÜRKT, KINIKH G, TURGAY M, TUTKAK H, DUMAN M, TOKGÖZ G: Evaluation of interleukin-6 in rheumatoid arthritis as an activity criterion. Rheumatol Int 1996; 16: 141-4.
27. STEFANOVIC-RACIC M, MEYERS K, MESCHTER C, COFFEY JW, HOFFMAN RA, EVANS CH: Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis. J Rheumatol 1995; 22: 1922-8.
28. STEFANOVIC-RACIC M, STADLER J, EVANS CH: Nitric oxide and arthritis. Arthritis Rheum 1993; 36: 1036-44.
29. STEFANOVIC-RACIC M, STADLER J, GEORGESCU HI, EVANS CH: Nitric oxide synthesis and its regulation by rabbit synoviocytes. J Rheumatol 1994; 21: 1892-8.
30. SAKURAI H, KOHSAKA H, LIU MF et al.: Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96: 2357-63.
31. STEFANOVIC-RACIC M, MEYERS K, MESCJTER C, COFFEY JW, HOFFMANN RA, EVANS CH: N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats. Arthritis Rheum 1994; 37: 1062-9.
32. IALENTI A, MONCADA S, DIROSA M: Modulation of adjuvant arthritis by endogenous nitric oxide. Br J Pharmacol 1993; 110: 701-6.
33. MURRELL GAC, JANG D, WILLIAMS RJ: Nitric oxide activates metalloproteinase enzymes in articular cartilage. Biochem Biophys Res Com 1995; 206: 15-21.
34. DIGIOVINE FS, NUKI G, DUFF GW: Tumor necrosis factor in synovial exudates. Ann Rheum Dis 1988; 47: 468-72.
35. DUFF GW: Cytokines and acute phase proteins in rheumatoid arthritis. Scand J Rheumatol 1994; 23 (Suppl. 100): 9-19.
36. WESTACOTT CI, WHICHER JT, BARNES IC, THOMPSON D, SWAN AJ, DIEPPE PA. Synovial fluid concentration of five different cytokines in rheumatic diseases. Ann Rheum Dis 1990; 49: 676-81.
37. GEARING AJH, BECKETT P, CHRISTODOULOU M et al.: Processing of tumour necrosis factor-α precursor by metalloproteases. Nature 1994; 370: 555-7.
38. ZVAIFLER NJ, FIRESTEIN GS: Pannus and pannocytes. Arthritis Rheum 1994;37:783-9.
39. UNEMORI EN, HIBBS MS, AMENTO EP: Constitutive expression of a 92kDa gelatinase (type IV collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J Clin Invest 1991; 88: 1656-62.
40. BUCALA R, RITCHLIN C, WINCHESTER R, CERAMI A: Constitutive production of inflammatory and mitogenic cytokines by rheumatoid synovial fibroblasts. J Exp Med 1991; 173: 569-74.
41. OKADA Y, MORODOMIT, ENGHILD JJ et al.: Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts - Purification and activation of the precursor and enzymic properties. Eur J Biochem 1990; 194: 721-30.
42. TETLOW LC, LEES M, OGATA Y, NAGASE H, WOOLLEY DE: Differential expression of gelatinase B (MMP9) and stromelysin 1 (MMP3) by rheumatoid synovial cells in vivo and in vitro. Rheumatol Int 1993; 13: 53-9.
43. WAHL LM, CORCORAN ML: Regulation of monocyte/macrophage metalloproteinase production by cytokines. J Periodontol 1993; 64: 467-73.
44. CAWSTON TE, BILLINGTON C: Metalloproteinases in the rheumatic diseases. J Pathol 1996; 180: 115-7.
45. KIKUCHI H, SHIMADA W, NONAKA T, UESHIMA S, TANAKA S: Significance of serine proteinase and matrix metalloproteinase systems in the destruction of human articular cartilage. Clin Exp Pharmacol Physiol 1996; 23: 885-9.
46. VINCENTI MP, CLARK IM, BRINCKERHOFF CE: Using inhibitors of metalloproteinases to treat arthritis. Arthritis Rheum 1994; 37: 1115-26.